Successful treatment with lorlatinib in a patient with meningeal carcinomatosis of ALK-positive non-small cell lung cancer resistant to alectinib and brigatinib: A case report

RATIONALE: Although anaplastic lymphoma kinase (ALK) inhibitors are effective treatment options for ALK-positive non-small cell lung cancer (NSCLC) with central nervous system (CNS) metastasis, achieving long-term survival in patients with NSCLC with meningeal carcinomatosis resistant to ALK inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakashima, Koki, Demura, Yoshiki, Kurokawa, Kosuke, Takeda, Toshihiro, Jikuya, Norihiro, Oi, Masahiro, Tada, Toshihiko, Akai, Masaya, Ishizuka, Tamotsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483815/
https://www.ncbi.nlm.nih.gov/pubmed/34596160
http://dx.doi.org/10.1097/MD.0000000000027385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483815/
https://www.ncbi.nlm.nih.gov/pubmed/34596160
http://dx.doi.org/10.1097/MD.0000000000027385

Ejemplares similares